Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Azithromycin Powder for Oral Suspension versus ZITHROMAX in healthy Thai volunteers under fasting conditions
TCTR20170227004Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azithromycin in bacterial disease (2 arms), sponsored by Bio-innova. Planned start Mar 2017; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on TCTR20170227004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170227004.